With the 24% cuts and PEPFAR discontinued, we estimated there could be 4.43 million to 10.75 million additional HIV ...

31, 2025 — In a new study, researchers have determined that a protein called NF-kB c-Rel can intensify the symptoms ... about HIV. Fewer people know about its relative, HTLV-1.

This class of drugs works by blocking the protein shell of the HIV-1 virus, known as the capsid ... The best way to keep HIV symptoms and complications at bay is to maintain the doctor-prescribed ...

People with HIV who continue treatment can live without symptoms and don’t risk infecting ... annual new HIV infections by 39% (from 2.1 million in 2010 to 1.3 million in 2023), and annual ...

The global HIV antivirals market is experiencing substantial growth, fueled by rising global awareness, advancements in pharmaceutical research, and the increasing adoption of innovative treatment ...

One dose of the Jynneos vaccine was 58% effective against mpox infection overall and 84% in people without HIV, but only 35% ...